ArticleJournal of oncology2022

Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway.

Sun Guangshun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.